Re: Blocking oncogenic Ras signaling for cancer therapy.

Journal of the National Cancer Institute ·Vol. 94 ·No. 13 ·2002-07-03 ·Pages 1031-2; author reply 1032

Canevari S, Biocca S, Figini M

Abstract

暂无摘要

MeSH Terms

Alkyl and Aryl Transferases/antagonists & inhibitors Animals Antineoplastic Agents/pharmacology Cell Cycle Cell Division Genes, ras/drug effects Genetic Therapy Humans Mutation/drug effects Neoplasms/genetics,therapy Oligonucleotides, Antisense/pharmacology Protein Prenylation Signal Transduction/drug effects ras Proteins/drug effects,genetics

Chemicals

Antineoplastic Agents Oligonucleotides, Antisense Alkyl and Aryl Transferases geranylgeranyltransferase type-I p21(ras) farnesyl-protein transferase ras Proteins

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

Canevari Silvana

Biocca Silvia

Figini Mariangela

Article Info

Journal

Journal of the National Cancer Institute

Abbr.

J Natl Cancer Inst

ISSN

0027-8874

DOI

10.1093/jnci/94.13.1031

Published

2002-07-03

Pages

1031-2; author reply 1032

Language

English

Region

United States

NLM ID

7503089

Subset

Corrections

CommentOn

PMID: 11459867

External Links

PubMed source DOI: 10.1093/jnci/94.13.1031 View journal details

Analysis Services

Re: Blocking oncogenic Ras signaling for cancer therapy.

Contact

WeChat Official Account